C. Fukushima et al., INHIBITORY EFFECT OF THROMBOXANE A(2) SYNTHETASE INHIBITOR, DP-1904, ON ANTIGEN-INDUCED CONTRACTION OF HUMAN LUNG PARENCHYMA, Annals of allergy, asthma, & immunology, 77(6), 1996, pp. 483-487
Background: Several mediators are released from mast cells during alle
rgic reactions. These substances cause contraction of airway smooth mu
scles, increase the permeability of blood vessels, and enhance mucous
secretion. Among these mediators, thromboxane A(2) (TXA(2)) has a part
icularly strong bronchoconstrictive effect. Objectives: We examined an
tigen-induced contraction of excised human lungs and the suppressive e
ffects of TXA(2) synthetase inhibitor on TXA(2) release. Methods: Huma
n lung parenchymal strips were subjected to passive sensitization with
sera of 5+ RAST titer to the mite. They were suspended in magnus bath
s, to which buffer and 10(-4) to 10(-8) M of DP-1904, an inhibitor of
TXA(2) synthetase, were added. Following the measurement of TXB(2) and
leukotriene (LT) concentrations in each bath, parenchymal contraction
was induced by the addition of a mite antigen. The concentration of T
XB(2) and LT was measured after contraction. Results: Antigen-induced
release of TXB(2) was significantly suppressed by DP-1904 in a concent
ration-dependent manner. DP-1904 did not inhibit parenchymal contracti
on and the release of LT. Conclusions: Antigen-induced parenchymal con
traction was not suppressed by inhibition of TXA(2) release, suggestin
g that DP-1904 may not be effective in asthma.